In the MTS assays of IMAC-refined diabodies, damage to cancer cells by diabodies containing anti-CD3 domains was greater for LH-type than for HL-type diabodies, and diabodies containing anti-CD28 domains caused a low level of cancer cell damage. This evidence concerns the gene CD28 and cancer.